Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.

Quentin RillerCamille CotteretHelga JunotNeila BenameurJulien HarocheAlexis MathianMiguel HieMakoto MiyaraPatrick TilleulZahir AmouraFleur Cohen-Aubart

Published in: Journal of neurology (2019)

In this retrospective study, the infliximab biosimilar was efficacious and safe for treating neurosarcoidosis.

Keyphrases

ulcerative colitis
combination therapy
replacement therapy